May 16 |
OncoCyte Corporation (OCX) Q1 2024 Earnings Call Transcript
|
May 15 |
OncoCyte GAAP EPS of -$1.13 misses by $0.46, revenue of $0.18M misses by $0.17M
|
May 15 |
Oncocyte Reports First Quarter 2024 Financial Results
|
May 14 |
OncoCyte Q1 2024 Earnings Preview
|
May 13 |
OncoCyte files to sell 5.42M shares of common stock for holders
|
May 13 |
Oncocyte to Announce First Quarter 2024 Financial Results
|
May 7 |
PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace
|
Apr 15 |
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
|
Apr 12 |
OncoCyte Corporation (OCX) Q4 2023 Earnings Call Transcript
|
Apr 12 |
Top 3 Health Care Stocks That May Collapse In Q2
|